News Sentiment

PGNY sentiment intelligence

Progyny Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 59 Balanced news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Healthcare Plans Read-through group
Latest close 30.65 Week of 10 Jul 2026
Weighted tone 59/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+1.4% over one week, +15.1% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Progyny (PGNY) Stock May Be 50% Undervalued On Fresh Analyst Upgrades

Market Reaction

Balanced read

67/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction 1.4% Price digesting
Trend fit Trend active 15.1% over four weeks
Fair value 18.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 25
Neutral 26
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
simplywall.st 8
TradingView 6
Stock Titan 3
Moomoo 2
The Globe and Mail 2
Stock Traders Daily 2
Sahm 2

Event Lens

What the news is about

Classified themes
Market update 24
Earnings 16
Analyst action 8
Guidance 3
Capital return 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 53
Benzinga Direct company coverage

Top 3 Health Care Stocks That May Implode This Month

This article identifies three healthcare stocks, Progyny (PGNY), 10x Genomics (TXG), and Privia Health Group (PRVA), that are considered overbought based on their high Relative Strength Index (RSI) values and significant price gains over the past month. Despite recent upgrades by

Tone
Negative 36/100
Event
Market update
Published
15 Jul 2026 12:44
Source
Benzinga
Moomoo Direct company coverage

Progyny Price Target Raised to $35.00/Share From $30.00 by Keybanc

Keybanc has increased its price target for Progyny (NASDAQ: PGNY) to $35.00 per share, up from the previous target of $30.00. This adjustment reflects an updated outlook on the company's valuation.

Tone
Positive 74/100
Event
Analyst action
Published
14 Jul 2026 15:43
Source
Moomoo
Stock Titan Direct company coverage

[144] Progyny, Inc. SEC Filing

A Progyny, Inc. (PGNY) stockholder recently filed a Form 144 Notice of Proposed Sale of Securities, indicating an intent to sell 2,244 shares of common stock through Fidelity Brokerage Services LLC, valued at approximately $70,910.40. These shares originated from restricted stock

Tone
Neutral 50/100
Event
Market update
Published
14 Jul 2026 13:43
Source
Stock Titan
The Globe and Mail Direct company coverage

Stocks making big moves yesterday: RXO, Progyny, Cigna, GoodRx, and Domino's

This article highlights several stocks that experienced significant upward movement on Monday, including RXO, Progyny, Cigna, GoodRx, and Domino's. Each company's stock surge is attributed to positive analyst actions like price target increases or favorable company news such as n

Tone
Positive 67/100
Event
Analyst action
Published
14 Jul 2026 12:43
Source
The Globe and Mail
Moomoo Direct company coverage

Progyny Is Maintained at Overweight by Keybanc

Keybanc has reiterated its "Overweight" rating for Progyny. The company's financial standing and future prospects support this positive outlook. This maintenance of rating suggests continued confidence from Keybanc in Progyny's performance.

Tone
Positive 66/100
Event
Guidance
Published
14 Jul 2026 09:10
Source
Moomoo
The Globe and Mail Direct company coverage

Progyny (PGNY) Stock Is Up, What You Need To Know

Progyny (PGNY) stock rose 3.5% after KeyBanc increased its price target to $35 from $30, maintaining an "Overweight" rating due to expected strong earnings and increased guidance. This follows other bullish calls from analysts like Truist Securities and Canaccord Genuity, signali

Tone
Positive 70/100
Event
Earnings
Published
14 Jul 2026 08:42
Source
The Globe and Mail
Stock Traders Daily Direct company coverage

(PGNY) Movement Within Algorithmic Entry Frameworks

Quantitative Research Desk reports on Progyny Inc. (NASDAQ: PGNY), highlighting strong near and mid-term sentiment that could extend long-term, with no resistance levels identified above the current price. The report provides three AI-generated trading strategies—Position, Moment

Tone
Positive 74/100
Event
Market update
Published
13 Jul 2026 14:12
Source
Stock Traders Daily
Yahoo! Finance Canada Direct company coverage

Why Progyny (PGNY) Might be Well Poised for a Surge

Progyny (PGNY) is showing strong potential for growth due to a remarkably improving earnings outlook and rising analyst estimates. The company has a Zacks Rank #1 (Strong Buy), driven by positive revisions in both current-quarter and full-year earnings expectations. Investors are

Tone
Positive 71/100
Event
Earnings
Published
09 Jul 2026 16:42
Source
Yahoo! Finance Canada
Sahm Direct company coverage

Progyny (PGNY) Is Up 7.2% After Russell 2000 Dynamic Exit Triggers Index Rebalancing - Has The Bull Case Changed?

Progyny (PGNY) was recently removed from the Russell 2000 Dynamic Index, leading to a 7.2% stock price increase due to index rebalancing. While this event is seen as technical rather than fundamental, it highlights the importance of management's recent $200 million share repurcha

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 19:11
Source
Sahm
Investing.com South Africa Direct company coverage

Progyny stock hits 52-week high at 31.07 USD By Investing.com

Progyny Inc. stock has reached a 52-week high of $31.07, demonstrating a 44.2% one-year total return. The company reported strong first-quarter results, exceeding analyst expectations with $0.50 adjusted EPS and record revenue of $328.5 million. Analysts have responded by raising

Tone
Positive 94/100
Event
Earnings
Published
07 Jul 2026 15:41
Source
Investing.com South Africa
Insider Monkey Direct company coverage

12 Best Quality Stocks to Buy and Hold for the Next Decade

This article identifies Progyny, Inc. (NASDAQ: PGNY) as one of the best quality stocks for long-term investment, citing its strong market position in fertility benefits and impressive EPS growth projections. Analyst firms Truist and BofA have raised their price targets for Progyn

Tone
Positive 74/100
Event
Earnings
Published
04 Jul 2026 05:39
Source
Insider Monkey
Stock Traders Daily Direct company coverage

How (PGNY) Movements Inform Risk Allocation Models

This article analyzes Progyny Inc. (NASDAQ: PGNY) using AI models to inform risk allocation. Key findings suggest strong near and mid-term sentiment, potential for upside, and the absence of clear price positioning signals. It outlines three institutional trading strategies tailo

Tone
Positive 73/100
Event
Market update
Published
02 Jul 2026 13:14
Source
Stock Traders Daily
Sahm Direct company coverage

Does Progyny’s (PGNY) Index Exit Quietly Recast Its Long‑Term Competitive Positioning?

Progyny's removal from the Russell 2000 Dynamic Index casts a new light on its long-term competitive positioning amid existing concerns over soft demand and limited cost leverage. This exit may add short-term trading pressure but doesn't fundamentally alter its near-term guidance

Tone
Neutral 50/100
Event
Guidance
Published
01 Jul 2026 18:11
Source
Sahm
Finviz Direct company coverage

PGNY - Progyny Inc Volatility & Greeks

This article provides a detailed financial overview of Progyny Inc. (PGNY), including its volatility, key financial metrics, performance indicators, and market data. It covers various aspects like market capitalization, income, sales, P/E ratios, EPS, insider and institutional ow

Tone
Positive 60/100
Event
Earnings
Published
01 Jul 2026 16:39
Source
Finviz
www.marketscreener.com Direct company coverage

Progyny, Inc.(NasdaqGS: PGNY) dropped from Russell 2000 Dynamic Index

Progyny, Inc. (NasdaqGS: PGNY) has been removed from the Russell 2000 Dynamic Index. This news, published on June 29, 2026, details the company's current stock performance, recent analyst ratings, and its business profile as a benefit management company specializing in fertility

Tone
Negative 41/100
Event
Analyst action
Published
29 Jun 2026 21:39
Source
www.marketscreener.com
Investing.com Nigeria Direct company coverage

Progyny stock hits 52-week high at 28.76 USD By Investing.com

Progyny Inc. (PGNY) stock reached a new 52-week high of $28.76, bringing its market capitalization to $2.24 billion. This rise is attributed to strong demand for its fertility benefits services and positive analyst revisions, with the stock appearing undervalued. The company rece

Tone
Positive 74/100
Event
Analyst action
Published
29 Jun 2026 16:39
Source
Investing.com Nigeria
TradingView Direct company coverage

PGNY Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Progyny, Inc. (PGNY) stock, based on analyst ratings and current market performance. It details the company's financial metrics, including EPS, revenue, net income, and market capitalization, along with its stock price history

Tone
Positive 77/100
Event
Earnings
Published
28 Jun 2026 05:40
Source
TradingView
TradingView Direct company coverage

Progyny, Inc. Actuals & Estimates (NASDAQ:PGNY)

This article provides key financial data and analyst estimates for Progyny, Inc. (NASDAQ:PGNY), covering its stock price performance, forecasts, historical highs and lows, market capitalization, and earnings. It also includes information on the company's revenue, net income, empl

Tone
Positive 67/100
Event
Earnings
Published
28 Jun 2026 05:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Progyny, Inc. – NASDAQ:PGNY

This article provides a brief financial overview of Progyny, Inc. (NASDAQ:PGNY), specifically focusing on its price to sales forward metric. It indicates that the market was closed at the time of publication and there were no trades. The content also lists various features and se

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 03:09
Source
TradingView
TradingView Direct company coverage

Price to book forward of Progyny, Inc. – BX:PGNY

This article provides the "Price to book forward" financial metric for Progyny, Inc. (BX:PGNY) on TradingView. It shows that the metric is presented for a specific period, including its value, change, and percentage change. The data is supplied by ICE Data Services and FactSet.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 19:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Progyny, Inc. – NASDAQ:PGNY

This article provides financial information for Progyny, Inc. (NASDAQ: PGNY), focusing on its enterprise value to revenue forward. It appears to be a financial data point from TradingView, without further detailed analysis in the provided content.

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 12:09
Source
TradingView